Recurrence in tuberculosis: relapse or reinfection? (Q34194205)

31 July 2017

1 reference

title

Recurrence in tuberculosis: relapse or reinfection? (English)

1 reference

31 July 2017

0 references

5

Marleen Boelaert

1 reference

31 July 2017

Patrick Van der Stuyft

6

object named as

Patrick Van der Stuyft

1 reference

31 July 2017

Marie-Laurence Lambert

1

1 reference

31 July 2017

Epco Hasker

2

1 reference

31 July 2017

Armand Van Deun

3

1 reference

31 July 2017

Dominique Roberfroid

4

1 reference

31 July 2017

1 May 2003

1 reference

Lancet Infectious Diseases

31 July 2017

1 reference

31 July 2017

3

1 reference

31 July 2017

5

1 reference

31 July 2017

282-287

1 reference

Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Tuberculosis vaccine development: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Relapses in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Hong Kong Chest Service/tuberculosis Research Centre, Madras/British Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Genotypic patterns of multiple isolates of M. tuberculosis from tuberculous HIV patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Quality control in tuberculosis bacteriology. 2. The origin of isolated positive cultures from the sputum of patients in four studies of short course chemotherapy in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

Interpretation of cluster studies of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900607-8

7 January 2021

10.1016/S1473-3099(03)00607-8

Identifiers

DOI

1 reference

31 July 2017

1 reference